2mg CS0159: Clinical Trials

1 trial of 2mg CS0159, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow 2mg CS0159: new trials by email Literature Review of 2mg CS0159 trials Research Report on 2mg CS0159

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
2mg CS0159, Placebo - Primary Biliary Cholangitis
Phase 3RecruitingCascade Pharmaceuticals, Inc1352025-12-012026-11-12

Conditions studied

Liver Cirrhosis, Biliary (1)

Sponsors

Cascade Pharmaceuticals, Inc (1)

Countries

China (1)

Top investigators

Ma Xiong, MD (1)